1. Aman, M. G. (1991) Pharmacotherapy in the developmental disabilities: New developments.Aust. New Zeal. J. Devel. Dis. 17: 183?199.
2. Aman, M. G., and Singh, N. N. (1988). Patterns of drug use, methodological considerations, measurement techniques, and future trends. In Aman, M. G., and Singh, N. N., (eds.),Psychopharmacology of the Developmental Disabilities, Springer-Verlag, New York, pp. 1?28.
3. Aman, M. G., and Singh, N. N. (1991). Pharmacological intervention. In Matson, J. L., and Mulick, J. A. (eds.),Handbook of Mental Retardation (2nd ed), Pergamon Press, New York, pp. 347?372.
4. Barrett, R. P., Feinstein, C., and Hole, W. T. (1989). Effects of naloxone and naltrexone on self-injury: A double-blind placebo-controlled analysis.Am. J. Ment. Retard. 93: 644?651.
5. Basbaum, A. I., and Fields, H. L. (1984). Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry.Annu. Rev. Neurosc. 7: 1143?1152.